Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve

Internal Medicine

Volumn 49, Issue 16, 2010, Pages 1775-1777

  Katayama, Takuji ^a   Tsuruya, Yoshio ^a   Ishikawa, Susumu ^b  

^a Tokyo kita Social Insurance Hospital   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Endocarditis; Prosthetic valve; Stenotrophomonas maltophilia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZTREONAM; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MINOCYCLINE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

AGED; ANOREXIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BRAIN EMBOLISM; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART ABSCESS; HEMIPARESIS; HUMAN; KIDNEY DYSFUNCTION; MITRAL VALVE PROLAPSE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PANCYTOPENIA; PROSTHETIC VALVE ENDOCARDITIS; SINUS TACHYCARDIA; STENOTROPHOMONAS MALTOPHILIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ENDOCARDITIS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEART VALVE PROSTHESIS; HUMANS; MITRAL VALVE; PROSTHESIS-RELATED INFECTIONS; STENOTROPHOMONAS MALTOPHILIA;

EID: 77956197650     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3701     Document Type: Article

References (11)

1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11: 57-80, 1998.
2. Dignani MC, Grazziutti M, Anaissie E. Stenotrophomonas maltophilia infections. Semin Respir Crit Care Med 24: 89-98, 2003.
3. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9: 312-323, 2009.
4. Munter RG, Yinnon AM, Schlesinger Y, Hershko C. Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia. Eur J Clin Microbiol Infect Dis 17: 353-356, 1998.
5. Khan IA, Mehta NJ. Stenotrophomonas maltophilia endocarditis: a systematic review. Angiology 53: 49-55, 2002.
6. Crum NF, Utz GC, Wallace MR. Stenotrophomonas maltophilia endocarditis. Scand J Infect Dis 34: 925-927, 2002.
7. Bayle S, Rovery C, Sbragia D, Brouqui P. Stenotrophomonas maltophilia prosthetic valve endocarditis: a case report. J Med Case Reports 2: 174, 2008.
8. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633-638, 2000.
9. Takigawa M, Noda T, Kurita T, et al. Extremely late pacemakerinfective endocarditis due to Stenotrophomonas maltophilia. Cardiology 110: 226-229, 2008.
10. Muller-Premru M, Gabrijelcic T, Gersak B, et al. Cluster of Stenotrophomonas maltophilia endocarditis after prosthetic valve replacement. Wein Klin Wochenschr 120: 566-570, 2008.
11. Muder RR. Optimizing therapy for Stenotrophomonas maltophilia. Semin Respir Crit Care Med 28: 672-677, 2007.